Shukra Pharmaceuticals, 524632, Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,814.13
62.22
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,804.53
0.02%
21.05

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

21.04
23.82
-17.87

EBITDA CAGR (%)

10 Years
5 Years
3 Years

26.74
54.42
18.89

PAT CAGR (%)

10 Years
5 Years
3 Years

54.96
119.04
29.51

P:E (Median)

8 Years
5 Years
3 Years

26.68
31.71
43.58

P:BV (Average)

8 Years
5 Years
3 Years

6.02
6.91
10.59

EV:EBITDA (Average)

8 Years
5 Years
3 Years

22.45
28.23
39.11

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 39.14 10.58 269.94% 5.88 5.55 5.95% 5.39 3.18 69.50% 13.27 10.88 21.97%
Expenses 12.00 6.65 80.45% 6.30 4.89 28.83% 4.07 2.37 71.73% 5.95 6.45 -7.75%
EBITDA 27.14 3.94 588.83% -0.42 0.67 - 1.32 0.80 65.00% 7.32 4.43 65.24%
EBIDTM 69.34% 37.22% -7.15% 12.01% 24.45% 25.33% 55.16% 40.74%
Other Income 0.82 1.01 -18.81% 1.71 1.02 67.65% 1.11 0.72 54.17% 1.47 1.38 6.52%
Interest 0.28 0.15 86.67% 0.29 0.11 163.64% 0.27 0.06 350.00% 0.27 0.07 285.71%
Depreciation 0.84 0.70 20.00% 0.81 0.70 15.71% 0.79 0.67 17.91% 0.94 0.52 80.77%
PBT 26.83 4.10 554.39% 0.20 0.88 -77.27% 1.37 0.80 71.25% 7.57 5.22 45.02%
Tax 6.47 0.93 595.70% -2.18 0.34 - 0.34 0.31 9.68% 2.18 1.24 75.81%
PAT 20.37 3.17 542.59% 2.38 0.54 340.74% 1.03 0.49 110.20% 5.39 3.99 35.09%
PATM 52.04% 29.90% 40.48% 9.70% 19.09% 15.26% 40.59% 36.62%
EPS 0.47 0.07 571.43% 0.05 0.01 400.00% 0.02 0.01 100.00% 0.12 0.09 33.33%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 39.14 10.58 269.94% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 12.00 6.65 80.45% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 27.14 3.94 588.83% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 69.34% 37.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.82 1.01 -18.81% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.28 0.15 86.67% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.84 0.70 20.00% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 26.83 4.10 554.39% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 6.47 0.93 595.70% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 20.37 3.17 542.59% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 52.04% 29.90% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.47 0.07 571.43% 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 63.68 32.59 74.57 58.83 20.49 11.20 11.85 5.66 5.34 5.14 4.83 Net Sales Growth 110.93% -56.30% 26.76% 187.12% 82.95% -5.49% 109.36% 5.99% 3.89% 6.42% Cost Of Goods Sold 11.68 8.12 44.48 45.32 10.35 2.77 3.00 0.99 0.96 1.04 1.75 Gross Profit 52.00 24.48 30.09 13.52 10.14 8.43 8.84 4.67 4.39 4.09 3.07 GP Margin 81.66% 75.12% 40.35% 22.98% 49.49% 75.27% 74.60% 82.51% 82.21% 79.57% 63.56% Total Expenditure 28.32 19.86 55.17 53.47 17.60 9.75 10.31 4.01 3.73 3.67 3.64 Power & Fuel Cost - 0.00 0.00 0.00 0.00 1.78 1.64 0.34 0.29 0.26 0.26 % Of Sales - 0% 0% 0% 0% 15.89% 13.84% 6.01% 5.43% 5.06% 5.38% Employee Cost - 5.47 5.02 4.41 4.57 3.75 4.34 1.91 1.23 1.05 1.13 % Of Sales - 16.78% 6.73% 7.50% 22.30% 33.48% 36.62% 33.75% 23.03% 20.43% 23.40% Manufacturing Exp. - 0.55 0.13 0.12 0.09 0.05 0.03 0.02 0.02 0.02 0.00 % Of Sales - 1.69% 0.17% 0.20% 0.44% 0.45% 0.25% 0.35% 0.37% 0.39% 0% General & Admin Exp. - 5.10 2.95 3.36 2.50 1.35 1.29 0.73 1.22 1.12 0.32 % Of Sales - 15.65% 3.96% 5.71% 12.20% 12.05% 10.89% 12.90% 22.85% 21.79% 6.63% Selling & Distn. Exp. - 0.36 2.12 0.01 0.01 0.04 0.00 0.02 0.02 0.18 0.18 % Of Sales - 1.10% 2.84% 0.02% 0.05% 0.36% 0% 0.35% 0.37% 3.50% 3.73% Miscellaneous Exp. - 0.27 0.47 0.26 0.07 0.01 0.01 0.00 0.00 0.00 0.18 % Of Sales - 0.83% 0.63% 0.44% 0.34% 0.09% 0.08% 0% 0% 0% 0.21% EBITDA 35.36 12.73 19.40 5.36 2.89 1.45 1.54 1.65 1.61 1.47 1.19 EBITDA Margin 55.53% 39.06% 26.02% 9.11% 14.10% 12.95% 13.00% 29.15% 30.15% 28.60% 24.64% Other Income 5.11 4.21 2.82 1.20 0.08 0.36 0.01 0.04 0.11 0.07 0.19 Interest 1.11 0.59 0.28 0.28 0.29 0.03 0.00 0.00 0.04 0.01 0.00 Depreciation 3.38 3.00 2.05 1.84 1.66 1.47 1.48 0.96 0.74 0.47 0.45 PBT 35.97 13.34 19.88 4.44 1.02 0.29 0.07 0.72 0.95 1.06 0.92 Tax 6.81 3.76 1.35 0.04 0.27 -0.09 0.14 0.26 0.42 0.56 0.23 Tax Rate 18.93% 28.19% 6.79% 0.90% 26.47% -100.00% 82.35% 36.11% 44.21% 52.83% 65.71% PAT 29.17 9.58 18.54 4.41 0.75 0.19 0.04 0.46 0.53 0.50 0.12 PAT before Minority Interest 29.17 9.58 18.54 4.41 0.75 0.19 0.04 0.46 0.53 0.50 0.12 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 45.81% 29.40% 24.86% 7.50% 3.66% 1.70% 0.34% 8.13% 9.93% 9.73% 2.48% PAT Growth 256.17% -48.33% 320.41% 488.00% 294.74% 375.00% -91.30% -13.21% 6.00% 316.67% EPS 0.67 0.22 0.42 0.10 0.02 0.00 0.00 0.01 0.01 0.01 0.00

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 62.84 57.64 25.30 16.35 15.60 15.41 15.38 15.01 14.58 14.07 Share Capital 43.79 10.95 3.91 1.57 1.57 1.57 1.57 1.57 1.57 1.57 Total Reserves 19.05 46.69 21.38 14.78 14.03 13.85 13.81 13.44 13.01 12.51 Non-Current Liabilities 6.65 6.04 7.16 6.39 12.97 11.15 9.02 6.43 2.64 2.48 Secured Loans 1.64 1.25 0.90 0.85 0.66 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 1.48 1.41 2.87 2.28 9.11 8.05 6.06 3.58 0.04 0.04 Long Term Provisions 0.13 0.11 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 17.28 14.15 42.51 12.38 7.03 6.99 4.00 2.66 1.72 0.73 Trade Payables 9.22 7.22 33.62 8.59 5.33 6.46 3.15 1.93 1.14 0.52 Other Current Liabilities 5.09 6.03 8.78 3.47 0.93 0.00 0.00 0.00 0.00 0.00 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 2.97 0.90 0.10 0.32 0.77 0.52 0.85 0.73 0.58 0.21 Total Liabilities 86.77 77.83 74.97 35.12 35.60 33.55 28.40 24.10 18.94 17.28 Net Block 19.40 19.94 20.23 17.58 17.69 17.38 15.60 14.12 10.09 9.67 Gross Block 43.42 40.97 39.57 35.08 33.53 31.74 28.51 26.06 21.30 20.41 Accumulated Depreciation 24.03 21.02 19.33 17.50 15.83 14.36 12.90 11.94 11.20 10.74 Non Current Assets 21.34 21.60 21.89 19.24 19.55 19.09 17.32 15.83 11.86 11.40 Capital Work in Progress 1.95 1.66 1.66 1.66 1.66 1.66 1.66 1.66 1.72 1.68 Non Current Investment 0.00 0.00 0.00 0.00 0.19 0.05 0.05 0.05 0.04 0.04 Long Term Loans & Adv. 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 65.43 56.23 53.07 15.87 16.06 14.45 11.07 8.27 7.08 5.88 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 9.95 2.31 3.16 3.95 1.68 1.39 0.27 0.14 0.32 0.44 Sundry Debtors 8.77 24.51 30.19 7.40 9.75 7.95 5.35 2.93 2.47 0.94 Cash & Bank 12.12 9.98 3.97 0.29 0.50 0.13 0.25 0.06 0.52 1.74 Other Current Assets 34.59 6.19 7.97 0.17 4.12 4.99 5.20 5.14 3.77 2.77 Short Term Loans & Adv. 15.79 13.24 7.78 4.06 3.98 3.77 3.59 3.51 3.35 2.32 Net Current Assets 48.14 42.08 10.57 3.50 9.03 7.47 7.08 5.61 5.36 5.15 Total Assets 86.77 77.83 74.96 35.11 35.61 33.54 28.39 24.10 18.94 17.28

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 7.92 -5.20 3.17 7.99 0.54 1.24 0.26 0.84 -0.29 2.72 PBT 13.34 19.88 4.44 1.02 0.10 0.17 0.72 0.95 1.06 0.35 Adjustment 2.12 1.55 1.60 1.91 1.44 1.58 0.96 0.77 0.47 0.45 Changes in Working Capital -3.78 -26.00 -2.62 5.50 -1.00 -0.51 -1.28 -0.74 -1.43 2.00 Cash after chg. in Working capital 11.68 -4.57 3.42 8.43 0.54 1.24 0.41 0.98 0.10 2.79 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.00 Tax Paid -3.76 -0.62 -0.25 -0.44 0.00 0.00 -0.15 -0.18 -0.39 -0.08 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1.26 -1.20 -4.43 -1.53 -1.89 -3.11 -2.45 -4.75 -0.93 -0.41 Net Fixed Assets -2.74 -1.40 -4.49 -1.55 -1.79 -3.23 -2.45 -4.70 -0.93 -0.40 Net Investments 0.00 0.00 0.00 0.19 -0.14 0.00 0.00 -0.01 0.00 -0.01 Others 1.48 0.20 0.06 -0.17 0.04 0.12 0.00 -0.04 0.00 0.00 Cash from Financing Activity -4.52 12.41 4.94 -6.68 1.74 1.75 2.38 3.45 0.00 -1.16 Net Cash Inflow / Outflow 2.14 6.01 3.68 -0.21 0.38 -0.12 0.18 -0.46 -1.22 1.15 Opening Cash & Equivalents 9.98 3.97 0.29 0.50 0.13 0.25 0.06 0.52 1.74 0.59 Closing Cash & Equivalent 12.12 9.98 3.97 0.29 0.50 0.13 0.25 0.06 0.52 1.74

Financial Ratios

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 1.44 1.32 16.16 21.74 99.63 98.43 98.20 95.86 93.10 89.89 ROA 11.63% 24.26% 8.01% 2.12% 0.54% 0.11% 1.76% 2.44% 2.78% 0.67% ROE 15.90% 44.70% 21.16% 4.70% 1.21% 0.23% 3.04% 3.55% 3.51% 0.85% ROCE 21.80% 44.24% 18.85% 5.79% 0.54% 0.77% 3.62% 5.94% 7.41% 2.40% Fixed Asset Turnover 0.77 1.85 1.58 0.60 0.34 0.46 0.24 0.24 0.25 0.24 Receivable days 186.38 133.86 116.60 152.77 288.50 176.69 228.42 170.95 120.92 54.99 Inventory Days 68.70 13.39 22.06 50.20 50.01 22.02 11.47 14.59 26.67 67.13 Payable days 369.82 167.55 170.00 245.53 761.94 159.63 199.65 154.07 83.12 46.94 Cash Conversion Cycle -114.74 -20.30 -31.34 -42.56 -423.43 39.09 40.24 31.47 64.47 75.18 Total Debt/Equity 0.07 0.05 0.20 0.21 0.63 0.52 0.39 0.24 0.00 0.00 Interest Cover 23.42 70.77 16.82 4.55 3.94 84.02 1166.32 24.45 182.99 256.48

Top Investors:

renuka yogesh parikh

yogesh biharilal parikh

llp

Annual Reports:

News Update:

Shukra Pharma - Quarterly Results
5th Feb 2026, 00:00 AM

Read More
Shukra Pharmaceuticals enters into MoU with Borns Medical Robotics
5th Jan 2026, 15:51 PM

Borns Medical Robotics Inc. will contribute its expertise in surgical robotics platforms and Al-enabled technologies
Read More
Shukra Pharma gets Univlabs Technologies’ nod to sell laparoscopic sets in Gujarat
22nd Dec 2025, 14:42 PM

The authorisation is valid till March 2026
Read More
Shukra Pharmaceuticals gets authorized distributor certificate from Integra Medical Devices India
3rd Dec 2025, 16:44 PM

The authorization is valid till December 31, 2026, unless terminated earlier as per the terms of the letter
Read More

Shukra Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524632 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Shukra Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524632 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: